Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Diisopropylamine | HCID 7912 | — |
| Reactant | 1-(4'-Fluorophenyl)-1,3-DihydroIsobenzofuran-5-Carbonitrile | HCID 9856159 | — |
| Reactant | Butyllithium | HCID 178418339 | — |
| Solvent | 1,2-Dimethoxyethane | HCID 8071 | — |
| Product | Citalopram | HCID 2771 | 76% |
Reaction Steps
n-BuLi (1.6 N in hexane, 320 mL) is added to diisopropylamine (55 g, 0.5 mole) dissolved in DME (150 mL) at −50° C. over a nitrogen atmosphere. 1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (62 g, 0.26 mole) is dissolved in DME (500 mL) and added dropwise while the temperature is kept below −40° C. After addition (45 min), the dark red solution is stirred for an additional period of 20 min. 3-Dimethylpropylchloride (100 g, 0.82 mole) is added in one portion at −50° C. and the cooling is removed. After 60 min, the solution is warmed to 50° C. for 120 min. The reaction mixture is poured onto ice water (1 L) and extracted with toluene (2×500 mL). The organic phase is extracted with HCl (4 N, 500 mL). The acid solution is made alkaline (pH=10) with NaOH (10 N) and extracted with toluene (500 mL) which is washed with water (3×200 ml). The toluene phase is dried anhydrous Na2SO4 (50 g), treated with active carbon and the solvents are removed in vacuo. The title compound (64-71 g, 76-84%) is obtained as an oil.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06291689B1 |
|---|
| Source dataset | uspto-grants-2001_09 |
|---|
| ORD ID | ord-7dc83302199d45c8b06f23e90d04a70e |
|---|
| Source note | uspto-grants-2001_09 |
|---|